@article {184,
	title = {Antituberculosis Therapy (ATT) Induced Thrombocytopenia: A Case Report},
	journal = {International Journal of Pharmacology and Clinical Sciences},
	volume = {2},
	year = {2013},
	month = {December 2013},
	pages = {126-128},
	type = {Case Report},
	chapter = {126},
	abstract = {<p class="rtejustify">Thrombocytopenia is a rare adverse effect seen with anti-tubercular drugs. We report an 80 year old male with tuber-cular right pleural effusion, on Category I Anti-tubercular therapy (ATT) for 3 weeks who presented with melena and epistaxis. On evaluation, he had thrombocytopenia which was found to be rifampicin-induced. ATT was restarted with-out rifampicin and there were no bleeding episodes. Though, rifampicin is well tolerated, but on rare occasions it can cause thrombocytopenia.</p>
},
	keywords = {ATT, Intermittent regimen, Rifampicin, Thrombocytopenia, Tuberculosis},
	author = {R. Dinesh Prabhu and G. Vikneswaran and Chultin Lepcha and N. Tombi Singh}
}
